Leaflet JUMEX 5mg tablets
Indicated for: Parkinson's disease
Route of administration: oral
Substance: selegiline (antiparkinsonian agent)
ATC: N04BD01 (Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may cause drowsiness or reduced alertness.
Selegiline is a medication used in the treatment of Parkinson's disease and, occasionally, major depression. It acts as a selective monoamine oxidase type B (MAO-B) inhibitor, increasing dopamine levels in the brain and improving motor symptoms of Parkinson's disease.
The medication is taken orally, as directed by a doctor, usually once or twice daily. It is important for patients to follow the treatment regimen and avoid tyramine-rich foods to prevent adverse reactions.
Patients should be aware of potential side effects, such as dizziness, nausea, or insomnia. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, nausea, and insomnia. In rare cases, severe reactions such as high blood pressure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about JUMEX 5mg
- Substance: selegiline
- Date of latest medicines list: 01-10-2013
- Product code: W12444001
- Concentration: 5mg
- Pharmaceutical form: tablets
- Quantity: 50
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Pharmaceutical forms available for selegiline
Concentrations available for selegiline
- 10mg
- 5mg